Augmenting regulatory T cells : new therapeutic strategy for rheumatoid arthritis
Copyright © 2024 Zhang, Liu, Chen, Liu, Zhang, Yin and Xie..
Rheumatoid arthritis (RA) is a chronic, systemic autoimmune condition marked by inflammation of the joints, degradation of the articular cartilage, and bone resorption. Recent studies found the absolute and relative decreases in circulating regulatory T cells (Tregs) in RA patients. Tregs are a unique type of cells exhibiting immunosuppressive functions, known for expressing the Foxp3 gene. They are instrumental in maintaining immunological tolerance and preventing autoimmunity. Increasing the absolute number and/or enhancing the function of Tregs are effective strategies for treating RA. This article reviews the studies on the mechanisms and targeted therapies related to Tregs in RA, with a view to provide better ideas for the treatment of RA.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
Frontiers in immunology - 15(2024) vom: 01., Seite 1312919 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Jiaqian [VerfasserIn] |
---|
Links: |
---|
Themen: |
Foxp3 |
---|
Anmerkungen: |
Date Completed 08.02.2024 Date Revised 03.04.2024 published: Electronic-eCollection Citation Status MEDLINE |
---|
doi: |
10.3389/fimmu.2024.1312919 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368114643 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368114643 | ||
003 | DE-627 | ||
005 | 20240404234735.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240207s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fimmu.2024.1312919 |2 doi | |
028 | 5 | 2 | |a pubmed24n1364.xml |
035 | |a (DE-627)NLM368114643 | ||
035 | |a (NLM)38322264 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Jiaqian |e verfasserin |4 aut | |
245 | 1 | 0 | |a Augmenting regulatory T cells |b new therapeutic strategy for rheumatoid arthritis |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.02.2024 | ||
500 | |a Date Revised 03.04.2024 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 Zhang, Liu, Chen, Liu, Zhang, Yin and Xie. | ||
520 | |a Rheumatoid arthritis (RA) is a chronic, systemic autoimmune condition marked by inflammation of the joints, degradation of the articular cartilage, and bone resorption. Recent studies found the absolute and relative decreases in circulating regulatory T cells (Tregs) in RA patients. Tregs are a unique type of cells exhibiting immunosuppressive functions, known for expressing the Foxp3 gene. They are instrumental in maintaining immunological tolerance and preventing autoimmunity. Increasing the absolute number and/or enhancing the function of Tregs are effective strategies for treating RA. This article reviews the studies on the mechanisms and targeted therapies related to Tregs in RA, with a view to provide better ideas for the treatment of RA | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Foxp3 | |
650 | 4 | |a Th17 | |
650 | 4 | |a regulatory T cells | |
650 | 4 | |a rheumatoid arthritis | |
650 | 4 | |a therapy | |
700 | 1 | |a Liu, Hongjiang |e verfasserin |4 aut | |
700 | 1 | |a Chen, Yuehong |e verfasserin |4 aut | |
700 | 1 | |a Liu, Huan |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Shengxiao |e verfasserin |4 aut | |
700 | 1 | |a Yin, Geng |e verfasserin |4 aut | |
700 | 1 | |a Xie, Qibing |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in immunology |d 2010 |g 15(2024) vom: 01., Seite 1312919 |w (DE-627)NLM215811453 |x 1664-3224 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2024 |g day:01 |g pages:1312919 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fimmu.2024.1312919 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2024 |b 01 |h 1312919 |